Clinical Trial Update: Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of Xisomab 3G3 in healthy adults completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• Xisomab 3G3 (Xisomab 3G3)

Snippet

Sponsor: Aronora, Inc. | Conditions: Thrombosis | Phase 1 | Status: COMPLETED | Results posted: 2019-05-20